Program Co-Chairs

Carol Wysham, MD
Section Head
Rockwood Center
Clinical Associate Professor
University of Washington
Spokane, WA

Marie E. McDonnell, MD
Diabetes Section Chief
Brigham and Women’s Hospital
Harvard University
Boston, MA

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following patient representative reported no relevant financial relationships during the content development process for this activity: Marie E. McDonnell, MD

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: 
Carol Wysham, MD: Consulting, Astra Zeneca, Abbott, Janssen, Novo Nordisk, Sanofi; Speaker, Astra Zeneca, Boehringer Ingelheim, Janssen, Novo Nordisk, Sanofi; Research, Abbott, Novo Nordisk, Mylan, Lilly  

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:  Beret Ann Casey, MD

The following SPC Committee members reported financial relationships:
Andjela T. Drincic, MD: Advisory Board Member, Corcept
Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca
Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health
Jonathan Purnell, MD: Advisor, Novo Nordisk
Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck
Susmeeta Sharma, MD: Speaker, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Lorena Alarcon-Casas Wright, MD, Deborah Sellmeyer, MD, Neena Natt, MD, Steven Weitzman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.